Struggling to understand why the market is so hot for CYP when there appear to be serious unresolved issues about the source of their cells. The RGS cells seem to have no such issues because they are not from reprogrammed adult cells
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor